TEST BANK
Pharmacology and the Nursing Process 9th
Edition By Lilley, Collins, and Snyder
All Chapters 1 to 58
NURSINGTB.COM
,Contents
Chapter 01: The Nursing Process and Drug Therapy ......................................................................... 4
b67 b67 b67 b67 b67 b67 b67
Chapter 02: Pharmacologic Principles ............................................................................................. 8
b67 b67 b67
Chapter 03: Lifespan Considerations ............................................................................................. 14
b67 b67 b67
Chapter 04: Cultural, Legal, and Ethical Considerations .................................................................. 20
b67 b67 b67 b67 b67 b67
Chapter 05: Medication Errors: Preventing and Responding ............................................................ 26
b67 b67 b67 b67 b67 b67
Chapter 06: Patient Education and Drug Therapy ........................................................................... 29
b67 b67 b67 b67 b67 b67
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ....................................... 34
b67 b67 b67 b67 b67 b67 b67 b67
Chapter 08: Gene Therapy and Pharmacogenomics ........................................................................ 38
b67 b67 b67 b67 b67
Chapter 09: Photo Atlas of Drug Administration............................................................................. 41
b67 b67 b67 b67 b67 b67
Chapter 10: Analgesic Drugs ........................................................................................................ 50
b67 b67 b67
Chapter 11: General and Local Anesthetics .................................................................................... 57
b67 b67 b67 b67 b67
Chapter 12: Central Nervous System Depressants and Muscle Relaxants ........................................... 61
b67 b67 b67 b67 b67 b67 b67 b67
Chapter 13: Central Nervous System Stimulants and Related Drugs.................................................. 66
b67 b67 b67 b67 b67 b67 b67 b67
Chapter 14: Antiepileptic Drugs.................................................................................................... 70
b67 b67 b67
Chapter 15: Antiparkinson Drugs..................N..U
b67 b67 ...R..S..I.N
...G
...T..B...C
...O..M
..........................................................................................................................................76
b67
Chapter 16: Psychotherapeutic Drugs ........................................................................................... 81
b67 b67 b67
Chapter 17: Substance Use Disorder.............................................................................................. 88
b67 b67 b67 b67
Chapter 18: Adrenergic Drugs ...................................................................................................... 93
b67 b67 b67
Chapter 19: Adrenergic-Blocking Drugs ........................................................................................ 98
b67 b67 b67
Chapter 20: Cholinergic Drugs ................................................................................................... 103
b67 b67 b67
Chapter 21: Cholinergic-Blocking Drugs ..................................................................................... 108
b67 b67 b67
Chapter 22: Antihypertensive Drugs ........................................................................................... 113
b67 b67 b67
Chapter 23: Antianginal Drugs ................................................................................................... 119
b67 b67 b67
Chapter 24: Heart Failure Drugs ................................................................................................. 125
b67 b67 b67 b67
Chapter 25: Antidysrhythmic Drugs............................................................................................ 131
b67 b67 b67
Chapter 26: Coagulation Modifier Drugs ..................................................................................... 137
b67 b67 b67 b67
Chapter 27: Antilipemic Drugs ................................................................................................... 143
b67 b67 b67
Chapter 28: Diuretic Drugs......................................................................................................... 148
b67 b67 b67
Chapter 29: Fluids and Electrolytes ............................................................................................. 154
b67 b67 b67 b67
Chapter 30: Pituitary Drugs ........................................................................................................ 160
b67 b67 b67
NURSINGTB.COM
,Chapter 31: Thyroid and Antithyroid Drugs ................................................................................. 163
b67 b67 b67 b67 b67
Chapter 32: Antidiabetic Drugs................................................................................................... 168
b67 b67 b67
Chapter 33: Adrenal Drugs ......................................................................................................... 177
b67 b67 b67
Chapter 34: Women’s Health Drugs ............................................................................................ 181
b67 b67 b67 b67
Chapter 35: Men’s Health Drugs ................................................................................................. 188
b67 b67 b67 b67
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants .................................. 193
b67 b67 b67 b67 b67 b67
Chapter 37: Respiratory Drugs.................................................................................................... 198
b67 b67 b67
Chapter 38: Antibiotics Part 1 ..................................................................................................... 204
b67 b67 b67 b67
Chapter 39: Antibiotics Part 2 ..................................................................................................... 211
b67 b67 b67 b67
Chapter 40: Antiviral Drugs ....................................................................................................... 216
b67 b67 b67
Chapter 41: Antitubercular Drugs ............................................................................................... 221
b67 b67 b67
Chapter 42: Antifungal Drugs..................................................................................................... 226
b67 b67 b67
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs................................................. 231
b67 b67 b67 b67 b67 b67
Chapter 44: Anti-inflammatory and Antigout Drugs ..................................................................... 236
b67 b67 b67 b67 b67
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs ............... 242
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs .... 248
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
NURSINGTB.COM
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs............................................. 253
b67 b67 b67 b67 b67 b67
Chapter 48: Immunosuppressant Drugs....................................................................................... 258
b67 b67 b67
Chapter 49: Immunizing Drugs .................................................................................................. 263
b67 b67 b67
Chapter 50: Acid-Controlling Drugs ........................................................................................... 268
b67 b67 b67
Chapter 51: Bowel Disorder Drugs .............................................................................................. 274
b67 b67 b67 b67
Chapter 52: Antiemetic and Antinausea Drugs ............................................................................. 281
b67 b67 b67 b67 b67
Chapter 53: Vitamins and Minerals ............................................................................................. 286
b67 b67 b67 b67
Chapter 54: Anemia Drugs ......................................................................................................... 292
b67 b67 b67
Chapter 55: Nutritional Supplements .......................................................................................... 299
b67 b67 b67
Chapter 56: Dermatologic Drugs ................................................................................................ 304
b67 b67 b67
Chapter 57: Ophthalmic Drugs ................................................................................................... 310
b67 b67 b67
Chapter 58: Otic Drugs .............................................................................................................. 315
b67 b67 b67
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK b67 b67 b67 b67 b67 b6 7 b67 b67 b67
Chapter 01: The Nursing Process and Drug Therapy b67 b67 b67 b67 b67 b67 b67
4
Chapter 01: The Nursing Process and Drug Therapy b67 b67 b67 b67 b67 b67 b67
MULTIPLE CHOICE b67
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6
7diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6
7diagnosis?
a. Anxiety
b. Anxietyrelated to new drug therapy 7
6
b b67 b67 b67 b67
c. Anxietyrelated to anxious feelings about drug therapy, as evidenced by statements 7
6
b b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
such as “I’m upset about having to test my blood sugars.” b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
d. Anxietyrelated to new drug therapy, as evidenced by statements such as “I’m 7
6
b b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
upset about having to test my blood sugars.” b67 b67 b67 b67 b 67 b67 b67
ANS: D b67b 6 7
Formulation of nursing diagnoses is usually a three- b67 b67 b67 b67 b67 b67 b67
step process. “Anxiety” is missing the “related to” and “as evidenced by” portions of defining
b67 b67 b67 b67 b67 b 6 7 b67 b67 b67 b67 b67 b67 b67 b67 b67
characteristics. “Anxietyrelated to new drug therapy” is missing the “as evidenced by” portio b67 7
6
b b67 b67 b 6 7 b67 b67 b67 b67 b67 b67 b67 b67
n of defining characteristics. The statement beginning “Anxiety related to anxious feelings” i
b67 b67 b67 b67 b67 b 6 7 b67 b67 b67 b67 b67 b67
s incorrect because the “related to” section is simply a restatement of the problem “anxiety,” n
b6 7 b67 b67 b67 b67 b67 b67 b 6 7 b67 b67 b67 b67 b67 b67 b67
ot a separate factor related to the response.
b67 b67 b67 b67 b67 b67 b67
DIF:
COGNITIVE LEVEL: Understanding (Comprehensi b67 b67 b67
on) TOP: NURSING PROCESS: Nursing DiagNnUosRiSs ING
b 6 7 b67b 6 7 b67 b67 b67
TB.COM
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
b 6 7 b67 b67 b67 b67 b67 b67 b67 b67
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
b 6 7 gave the medication 2 hours after the scheduled dose was due. What type of problem does thi
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
s b 6 7represent?
a. “Right time” b67
b. “Right dose” b67
c. “Right route” b67
d. “Right medication” b67
ANS: A b67b 6 7
“Right time” is correct because the medication was given more than 30 minutes after the sche
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b6 7 b67 b67 b 6 7
duled dose was due. “Dose” is incorrect because the dose is not related to the time the medicati
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6 7
on administration is scheduled. “Route” is incorrect because the route is not affected. “Medic
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6 7
ation” is incorrect because the medication ordered will not change. b67 b67 b67 b67 b67 b67 b67 b67 b67
DIF:
COGNITIVE LEVEL: Applying (Applicatio b67 b67 b67
n) TOP: NURSING PROCESS: Implementation
b 6 7 b67b 6 7 b67 b67
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
b 6 7 b67 b67 b67 b67 b67 b67 b67 b67 b67
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b
6 and documenting the patient’s therapeutic response to the medication. Which phase of the
7 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6 7
nursing process do these actions illustrate? b67 b67 b67 b67 b67
a. Nursing diagnosis b67
NURSINGTB.COM
Pharmacology and the Nursing Process 9th
Edition By Lilley, Collins, and Snyder
All Chapters 1 to 58
NURSINGTB.COM
,Contents
Chapter 01: The Nursing Process and Drug Therapy ......................................................................... 4
b67 b67 b67 b67 b67 b67 b67
Chapter 02: Pharmacologic Principles ............................................................................................. 8
b67 b67 b67
Chapter 03: Lifespan Considerations ............................................................................................. 14
b67 b67 b67
Chapter 04: Cultural, Legal, and Ethical Considerations .................................................................. 20
b67 b67 b67 b67 b67 b67
Chapter 05: Medication Errors: Preventing and Responding ............................................................ 26
b67 b67 b67 b67 b67 b67
Chapter 06: Patient Education and Drug Therapy ........................................................................... 29
b67 b67 b67 b67 b67 b67
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ....................................... 34
b67 b67 b67 b67 b67 b67 b67 b67
Chapter 08: Gene Therapy and Pharmacogenomics ........................................................................ 38
b67 b67 b67 b67 b67
Chapter 09: Photo Atlas of Drug Administration............................................................................. 41
b67 b67 b67 b67 b67 b67
Chapter 10: Analgesic Drugs ........................................................................................................ 50
b67 b67 b67
Chapter 11: General and Local Anesthetics .................................................................................... 57
b67 b67 b67 b67 b67
Chapter 12: Central Nervous System Depressants and Muscle Relaxants ........................................... 61
b67 b67 b67 b67 b67 b67 b67 b67
Chapter 13: Central Nervous System Stimulants and Related Drugs.................................................. 66
b67 b67 b67 b67 b67 b67 b67 b67
Chapter 14: Antiepileptic Drugs.................................................................................................... 70
b67 b67 b67
Chapter 15: Antiparkinson Drugs..................N..U
b67 b67 ...R..S..I.N
...G
...T..B...C
...O..M
..........................................................................................................................................76
b67
Chapter 16: Psychotherapeutic Drugs ........................................................................................... 81
b67 b67 b67
Chapter 17: Substance Use Disorder.............................................................................................. 88
b67 b67 b67 b67
Chapter 18: Adrenergic Drugs ...................................................................................................... 93
b67 b67 b67
Chapter 19: Adrenergic-Blocking Drugs ........................................................................................ 98
b67 b67 b67
Chapter 20: Cholinergic Drugs ................................................................................................... 103
b67 b67 b67
Chapter 21: Cholinergic-Blocking Drugs ..................................................................................... 108
b67 b67 b67
Chapter 22: Antihypertensive Drugs ........................................................................................... 113
b67 b67 b67
Chapter 23: Antianginal Drugs ................................................................................................... 119
b67 b67 b67
Chapter 24: Heart Failure Drugs ................................................................................................. 125
b67 b67 b67 b67
Chapter 25: Antidysrhythmic Drugs............................................................................................ 131
b67 b67 b67
Chapter 26: Coagulation Modifier Drugs ..................................................................................... 137
b67 b67 b67 b67
Chapter 27: Antilipemic Drugs ................................................................................................... 143
b67 b67 b67
Chapter 28: Diuretic Drugs......................................................................................................... 148
b67 b67 b67
Chapter 29: Fluids and Electrolytes ............................................................................................. 154
b67 b67 b67 b67
Chapter 30: Pituitary Drugs ........................................................................................................ 160
b67 b67 b67
NURSINGTB.COM
,Chapter 31: Thyroid and Antithyroid Drugs ................................................................................. 163
b67 b67 b67 b67 b67
Chapter 32: Antidiabetic Drugs................................................................................................... 168
b67 b67 b67
Chapter 33: Adrenal Drugs ......................................................................................................... 177
b67 b67 b67
Chapter 34: Women’s Health Drugs ............................................................................................ 181
b67 b67 b67 b67
Chapter 35: Men’s Health Drugs ................................................................................................. 188
b67 b67 b67 b67
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants .................................. 193
b67 b67 b67 b67 b67 b67
Chapter 37: Respiratory Drugs.................................................................................................... 198
b67 b67 b67
Chapter 38: Antibiotics Part 1 ..................................................................................................... 204
b67 b67 b67 b67
Chapter 39: Antibiotics Part 2 ..................................................................................................... 211
b67 b67 b67 b67
Chapter 40: Antiviral Drugs ....................................................................................................... 216
b67 b67 b67
Chapter 41: Antitubercular Drugs ............................................................................................... 221
b67 b67 b67
Chapter 42: Antifungal Drugs..................................................................................................... 226
b67 b67 b67
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs................................................. 231
b67 b67 b67 b67 b67 b67
Chapter 44: Anti-inflammatory and Antigout Drugs ..................................................................... 236
b67 b67 b67 b67 b67
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs ............... 242
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs .... 248
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
NURSINGTB.COM
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs............................................. 253
b67 b67 b67 b67 b67 b67
Chapter 48: Immunosuppressant Drugs....................................................................................... 258
b67 b67 b67
Chapter 49: Immunizing Drugs .................................................................................................. 263
b67 b67 b67
Chapter 50: Acid-Controlling Drugs ........................................................................................... 268
b67 b67 b67
Chapter 51: Bowel Disorder Drugs .............................................................................................. 274
b67 b67 b67 b67
Chapter 52: Antiemetic and Antinausea Drugs ............................................................................. 281
b67 b67 b67 b67 b67
Chapter 53: Vitamins and Minerals ............................................................................................. 286
b67 b67 b67 b67
Chapter 54: Anemia Drugs ......................................................................................................... 292
b67 b67 b67
Chapter 55: Nutritional Supplements .......................................................................................... 299
b67 b67 b67
Chapter 56: Dermatologic Drugs ................................................................................................ 304
b67 b67 b67
Chapter 57: Ophthalmic Drugs ................................................................................................... 310
b67 b67 b67
Chapter 58: Otic Drugs .............................................................................................................. 315
b67 b67 b67
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK b67 b67 b67 b67 b67 b6 7 b67 b67 b67
Chapter 01: The Nursing Process and Drug Therapy b67 b67 b67 b67 b67 b67 b67
4
Chapter 01: The Nursing Process and Drug Therapy b67 b67 b67 b67 b67 b67 b67
MULTIPLE CHOICE b67
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6
7diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6
7diagnosis?
a. Anxiety
b. Anxietyrelated to new drug therapy 7
6
b b67 b67 b67 b67
c. Anxietyrelated to anxious feelings about drug therapy, as evidenced by statements 7
6
b b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
such as “I’m upset about having to test my blood sugars.” b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
d. Anxietyrelated to new drug therapy, as evidenced by statements such as “I’m 7
6
b b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
upset about having to test my blood sugars.” b67 b67 b67 b67 b 67 b67 b67
ANS: D b67b 6 7
Formulation of nursing diagnoses is usually a three- b67 b67 b67 b67 b67 b67 b67
step process. “Anxiety” is missing the “related to” and “as evidenced by” portions of defining
b67 b67 b67 b67 b67 b 6 7 b67 b67 b67 b67 b67 b67 b67 b67 b67
characteristics. “Anxietyrelated to new drug therapy” is missing the “as evidenced by” portio b67 7
6
b b67 b67 b 6 7 b67 b67 b67 b67 b67 b67 b67 b67
n of defining characteristics. The statement beginning “Anxiety related to anxious feelings” i
b67 b67 b67 b67 b67 b 6 7 b67 b67 b67 b67 b67 b67
s incorrect because the “related to” section is simply a restatement of the problem “anxiety,” n
b6 7 b67 b67 b67 b67 b67 b67 b 6 7 b67 b67 b67 b67 b67 b67 b67
ot a separate factor related to the response.
b67 b67 b67 b67 b67 b67 b67
DIF:
COGNITIVE LEVEL: Understanding (Comprehensi b67 b67 b67
on) TOP: NURSING PROCESS: Nursing DiagNnUosRiSs ING
b 6 7 b67b 6 7 b67 b67 b67
TB.COM
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
b 6 7 b67 b67 b67 b67 b67 b67 b67 b67
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
b 6 7 gave the medication 2 hours after the scheduled dose was due. What type of problem does thi
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67
s b 6 7represent?
a. “Right time” b67
b. “Right dose” b67
c. “Right route” b67
d. “Right medication” b67
ANS: A b67b 6 7
“Right time” is correct because the medication was given more than 30 minutes after the sche
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b6 7 b67 b67 b 6 7
duled dose was due. “Dose” is incorrect because the dose is not related to the time the medicati
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6 7
on administration is scheduled. “Route” is incorrect because the route is not affected. “Medic
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6 7
ation” is incorrect because the medication ordered will not change. b67 b67 b67 b67 b67 b67 b67 b67 b67
DIF:
COGNITIVE LEVEL: Applying (Applicatio b67 b67 b67
n) TOP: NURSING PROCESS: Implementation
b 6 7 b67b 6 7 b67 b67
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
b 6 7 b67 b67 b67 b67 b67 b67 b67 b67 b67
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b
6 and documenting the patient’s therapeutic response to the medication. Which phase of the
7 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b67 b 6 7
nursing process do these actions illustrate? b67 b67 b67 b67 b67
a. Nursing diagnosis b67
NURSINGTB.COM
